Patent · US Active

Engineered polymerases for improved sequencing

US11242512B2 · kind B2 · utility

2Cited by
23References
14Claims
0Family size

Assignee

Inventor

Key dates

Filing dateSep 11, 2019
Grant dateFeb 8, 2022
Priority date
Expiry dateSep 11, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y207/07049
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Provided are nucleic acids encoding engineered polymerases comprising at least one modification in a motif A and/or at least one modification in a motif B of the polymerase and engineered polymerases encoded by the nucleic acids. Also provided are engineered DNA polymerases comprising a variant of SEQ ID NO:1, SEQ ID NO:2, or SEQ ID NO:3, the variant being at least 80% identical to SEQ ID NO:1, SEQ ID NO:2 or SEQ ID NO:3 and comprising an amino acid substitution at one or more positions selected from the group consisting of L408, Y409, P410, R484, A/L485, and I486. Methods, vectors, kits, and compositions comprising the nucleic acids and compositions, methods and kits comprising the engineered polymerases are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.